Early age type 1 diabetes linked to shorter life expectancy than later age diagnosis
Consider earlier and wider use of preventive treatment, researchers urge Related items fromOnMedica Too few women take part in many CVD clinical trials Children risking heart health through unhealthy lifestyles Hereditary heart and diabetes problems raise risk for children Regulators suspend Avandia over safety concerns Fat children have high cardiovascular risks as teens (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 10, 2018 Category: UK Health Source Type: news
Raised risk of MI and mortality when starting sulfonylurea
Continuing metformin when introducing sulfonylureas in type 2 diabetes safer than switching Related items fromOnMedica Sugar not saturated fat is the major issue for CVD Experts query risks of pioglitazone Regulators suspend Avandia over safety concerns Daily aspirin use linked to major bleeding Use of DPP-4 inhibitors associated with increased risk of IBD (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 19, 2018 Category: UK Health Source Type: news
Comunicado de la FDA sobre la seguridad de los medicamentos: FDA requiere que se eliminen ciertas restricciones al recetar y dispensar medicamentos para la diabetes que contienen rosiglitazona
El 25 de noviembre, 2013, La Administraci ón de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) ha determinado que datos recientes sobre medicamentos que contienen rosiglitazona, como Avandia, Avandamet, Avandaryl y versiones genéricas, no indican un riesgo mayor de ataque al corazón en comparación con los med icamentos estándar metformina y sulfonilurea para la diabetes de tipo 2. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 26, 2018 Category: Drugs & Pharmacology Source Type: news
FDA Drug Safety Communication: Avandia (rosiglitazone) labels now contain updated information about cardiovascular risks and use in certain patients
[2-03-2011] The U.S. Food and Drug Administration (FDA) is notifying the public that information on the cardiovascular risks (including heart attack) of the diabetes drug rosiglitazone has been added to the physician labeling and patient Medication Guide. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 11, 2017 Category: Drugs & Pharmacology Source Type: news
Jamaican weed stabilizes blood sugar
It was pouring rain. I could barely see as I drove up the winding mountains. But I would not be deterred from my mission.
I was on my way to finally meet Jamaica’s last living Maroon healer, Ivey Harris. I finally arrived at her secluded mountain home and she met me with open arms… and an umbrella.
After the rain let up, she showed me around her home. Her yard is like an all-natural pharmacy. And she’s a walking herbal encyclopedia.
One of my favorites was a Jamaican vine with weird-looking warty green fruit. Most people in the U.S. would call it a weed.
Today, I grow it in my backyard here in South Florida.
I ...
Source: Al Sears, MD Natural Remedies - December 7, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Health Avandia blood sugar diabetes diabetics drug glucose high-carb insulin Source Type: news
TSRI researchers explore ways that a drug like Avandia can be made safer
(Scripps Research Institute) With the heightened concerns over the dangerous side effects of the once-popular antidiabetic drug Avandia, researchers at The Scripps Research Institute (TSRI) in Jupiter, Florida, are working to understand how small molecules, like those in Avandia, can have such varied effects throughout the body. The insights could help researchers design new drugs with better efficacy and fewer side effects. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 29, 2017 Category: International Medicine & Public Health Source Type: news
FDA Drug Safety Communication: Reminder to healthcare providers and patients to enroll in the Avandia-Rosiglitazone Medicines Access Program
[11-04-2011] The U.S. Food and Drug Administration (FDA) is reminding healthcare providers and patients about the need to enroll in the Avandia-Rosiglitazone Medicines Access Program by November 17, 2011 in order to continue prescribing and receiving rosiglitazone-containing medicines (Avandia, Avandamet, and Avandaryl). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 1, 2017 Category: Drugs & Pharmacology Source Type: news
FDA Drug Safety Communication: FDA requires removal of some prescribing and dispensing restrictions for rosiglitazone-containing diabetes medicines
The U.S. Food and Drug Administration (FDA) has determined that recent data for rosiglitazone-containing drugs, such as Avandia, Avandamet, Avandaryl, and generics, do not show an increased risk of heart attack compared to the standard type 2 diabetes medicines metformin and sulfonylurea. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 1, 2017 Category: Drugs & Pharmacology Source Type: news
rosiglitazone, Avandia
Title: rosiglitazone, AvandiaCategory: MedicationsCreated: 11/28/1999 12:00:00 AMLast Editorial Review: 5/15/2017 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - May 15, 2017 Category: Endocrinology Source Type: news
Taking Aim At The Opioid Industry
Late last year, the Associated Press combined reporting with the Center for Public Integrity to roll out a multi-part series on the $880 million spent on lobbying and political contributions by the opioid industry in a decade long effort to stymie efforts to control these powerful drugs. Reporters reviewed of hundreds of documents brought to light in a recent court case and interviewed over 200 officials, experts, and advocates to understand how the opioid epidemic unfolded.
The series had its genesis when the AP’s Matthew Perrone tripped across a group called the Pain Care Forum. Led by the top lobbyist for Purdue P...
Source: Healthy Living - The Huffington Post - March 7, 2017 Category: Consumer Health News Source Type: news
Avandia (Rosiglitazone Maleate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 3, 2017 Category: Drugs & Pharmacology Source Type: news
Avandaryl (Rosiglitazone Maleate and Glimepiride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 19, 2016 Category: Drugs & Pharmacology Source Type: news
Avandamet (Rosiglitazone Maleate and Metformin HCl) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 18, 2016 Category: Drugs & Pharmacology Source Type: news
Expensive New Diabetes Drugs Add Nothing But Cost And Complications
This is the fourth in an ongoing series of blogs exposing the rampant misuse of the medications so aggressively promoted by greedy drug companies.
I am very lucky in having the perfect partner in this truth-vs-power effort to contradict Pharma propaganda with evidence based fact.
Dick Bijl is President of the International Society of Drug Bulletins (ISDB), an impressive association of 53 national drug bulletins from all around the world, each of which publishes the best available data on the pluses and minuses of different medications.
Drug bulletins help patients and doctors see through the misleading misinformation ge...
Source: Science - The Huffington Post - November 17, 2016 Category: Science Source Type: news
Avandamet (rosiglitazone/metformin)
Title: Avandamet (rosiglitazone/metformin)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 9/21/2016 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - September 21, 2016 Category: Endocrinology Source Type: news
